He was a senior leader of a major American corporation, and he looked the part. He was slender, well-groomed, and articulate. I was seeing him for the first time. His reason for the visit was chest pain. He had had two episodes and the most recent was 48 hours before the visit. He said the pains just came “out of the blue,” He was not anxious, upset, or exercising when the pain started. The pain lasted about ten minutes. He said it was about an eight on a scale of one to ten. He had never had anything like it before. It was in the center of his chest and involved his lower jaw. It had an oppressive, pressing quality. It alarmed him, and with good cause. Once the pain went away, he was fine.
In my case OMT and stents are the answer. Don't discount the viability and need for stents. I am alive by way of them and OMT. I have familial hypercholesterolemia. The idea of OMT is great , however in my case it requires Repatha (evolocumab) at a cost of about $1500 per month and insurance does not cover this med. I am also on other meds due to atherosclerosis. I am only 60 years old.
If you read more on this site you will see that I do talk about the situations where stents are important. Thanks for this question. When the patient dropped dead in the meeting room and was resuscitated, he was taken to the hospital and his artery was totally blocked with clot. Opening that acute blockage definitely saved heart muscle and may have saved his life. That is the setting in which stents are appropriate. I would not have a stent myself for stable heart artery disease unless OMT failed. If your stent was done for unstable angina or during a heart attack, it may well have saved your life. Otherwise, probably not. Repatha is a precision medicine for familial hypercholesterolemia.
Please refer to these links for the clinical validation work we have conducted over the past 20 years. Note, all of these trials were designed to ensure that our claims were proven based on the highest quality work with absolute, ground-breaking integrity. I chose only to work with independent investigators who conducted the validation work without ANY quid pro quo, deliberately avoiding the mainstream industry’s “normal” pay-to-play practices. I am very happy that I found these excellent colleagues from around the world who share the same values and passions as I do, wanting only to do the right thing - to prove beyond any doubt that our technology delivers what we intend. Therefore, I can proudly stand behind our technology without ANY reservations.
In addition, I have also included a chapter we wrote on invitation for Dr. Mark Houston describing our work. I also thought that the rebuttal letter written by my friend Darrin Menard to address the unfair treatment of our work by an AIM Cardiologist working for Louisiana BCBS is also relevant. Finally, a landmark study published by the BMJ’s OpenHeart which you have already seen, was the highlight of our clinical validation journey thus far.
In my case OMT and stents are the answer. Don't discount the viability and need for stents. I am alive by way of them and OMT. I have familial hypercholesterolemia. The idea of OMT is great , however in my case it requires Repatha (evolocumab) at a cost of about $1500 per month and insurance does not cover this med. I am also on other meds due to atherosclerosis. I am only 60 years old.
If you read more on this site you will see that I do talk about the situations where stents are important. Thanks for this question. When the patient dropped dead in the meeting room and was resuscitated, he was taken to the hospital and his artery was totally blocked with clot. Opening that acute blockage definitely saved heart muscle and may have saved his life. That is the setting in which stents are appropriate. I would not have a stent myself for stable heart artery disease unless OMT failed. If your stent was done for unstable angina or during a heart attack, it may well have saved your life. Otherwise, probably not. Repatha is a precision medicine for familial hypercholesterolemia.
Amazing info!
Thanks Dan. You are a walking testimonial.
Good article! I totally agree.
Thanks again for performing your test on me and Jean yesterday.
Your honest and thoughtful impressions will be much appreciated. Please share them. Thank you!
I will. I want to write about it. I want to get it right. It will take a few days.
I am happy to supply you the peer reviewed publications.
That would help
Good evening Bill,
Please refer to these links for the clinical validation work we have conducted over the past 20 years. Note, all of these trials were designed to ensure that our claims were proven based on the highest quality work with absolute, ground-breaking integrity. I chose only to work with independent investigators who conducted the validation work without ANY quid pro quo, deliberately avoiding the mainstream industry’s “normal” pay-to-play practices. I am very happy that I found these excellent colleagues from around the world who share the same values and passions as I do, wanting only to do the right thing - to prove beyond any doubt that our technology delivers what we intend. Therefore, I can proudly stand behind our technology without ANY reservations.
In addition, I have also included a chapter we wrote on invitation for Dr. Mark Houston describing our work. I also thought that the rebuttal letter written by my friend Darrin Menard to address the unfair treatment of our work by an AIM Cardiologist working for Louisiana BCBS is also relevant. Finally, a landmark study published by the BMJ’s OpenHeart which you have already seen, was the highlight of our clinical validation journey thus far.
https://www.dropbox.com/sh/9mocy51udgjpywd/AADA-wW0BvZ8KQmwUCxUOTIwa?dl=0
A Chapter of Dr. Mark Houston’s Book:
https://www.linkedin.com/pulse/multifunction-cardiogram-aka-mcg-chapter-12-december-2019-joseph-shen
https://www.linkedin.com/pulse/welcome-new-21st-century-digital-signal-processing-based-shen-md
https://www.dropbox.com/sh/yz321eddkc69kxm/AADgFAK8umsS-_bf6BaT2kuta?dl=0
A landmark study published by BMJ’s OpenHeart:
https://www.linkedin.com/posts/joseph-thomas-shen-md-b01760106_a-landmark-validation-trial-to-demonstrate-activity-6792463766555545602-yjYe
Looking forward to hearing your thoughts and feedback, especially your personal remarks on Lady Jean and your test results.
I am honored to work with you.
Best regards,
Joseph
Joseph T. Shen, MD